Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-035691

Director returned 3,300 shares (to the company)

  • Director acquired 3,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fust Matthew K Director 2023-06-07 Grant or award +3,860 30,355 D: show line 1 in the form
Fust Matthew K Director 2023-06-07 Returned to the company −3,300 $51.82 $171,006 27,055 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Fust Matthew K Director 2023-06-07 Grant or award · Stock Option (Right to Buy) +7,110 7,110 D: show line 3 in the form
Loading xslF345X04/doc4.xml…